I agree that this site is using cookies. You can find further informations here.
X
Curran, Kevin
315  results:
OpenAccess-fulltext X
Search for persons X
?
1

Outcomes After Nonresponse and Relapse Post-Tisagenlecleuce..:

Schultz, Liora ; Eaton, Anne ; Baggott, Christina...
qt6hg8d5pm.  , 2023
Link: https://escholarship.org..
 
?
2

HLH-like toxicities predict poor survival following use of ..:

McNerney, Kevin Owen ; Lim, Stephanie Si ; Ishikawa, Kyle...
qt29j0b626.  , 2023
Link: https://escholarship.org..
 
?
3

P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCA..:

Boissel, Nicolas ; Chevallier, Patrice ; Curran, Kevin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430638/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Higher doses of tisagenlecleucel associate with improved ou..:

Stefanski, Heather ; Eaton, Anne ; Baggott, Christina...
qt1vb4t9wc.  , 2023
Link: https://escholarship.org..
 
?
5

Qu'est-ce qu'un personnage ? : questions de théâtre:

Curran, Kevin ; Laughery, Vincent ; Reilly, Andrew.
info:eu-repo/semantics/altIdentifier/doi/10.55430/8019VA01.  , 2023
Link: https://archive-ouverte...
 
?
6

Mediport use as an acceptable standard for CAR T cell infus..:

Eylon, Maya ; Prabhu, Snehit ; John, Samuel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642031/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Mediport use as an acceptable standard for CAR T cell infus..:

Eylon, Maya ; Prabhu, Snehit ; John, Samuel...
qt1kh1f13z.  , 2023
Link: https://escholarship.org..
 
?
8

Third-party cytomegalovirus-specific T cells improved survi..:

Prockop, Susan E ; Hasan, Aisha ; Doubrovina, Ekaterina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178844/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Outcomes After Nonresponse and Relapse Post-Tisagenlecleuce..:

Schultz, Liora M ; Eaton, Anne ; Baggott, Christina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839307/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Association between busulfan exposure and survival in patie..:

Tamari, Roni ; Scordo, Michael ; Kunvarjee, Binni M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500467/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
qt18h5422h.  , 2023
Link: https://escholarship.org..
 
?
12

Excellent leukemia control after second hematopoietic cell ..:

Troullioud Lucas, Alexandre G ; Boelens, Jaap Jan ; Prockop, Susan E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465242/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Optimal fludarabine lymphodepletion is associated with impr..:

Fabrizio, Vanessa A ; Boelens, Jaap Jan ; Mauguen, Audrey...
qt6xt142fk.  , 2022
Link: https://escholarship.org..
 
?
14

Antithymocyte globulin exposure in CD34(+) T-cell–depleted ..:

Lakkaraja, Madhavi ; Scordo, Michael ; Mauguen, Audrey...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945304/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Real-World Use of Tisagenlecleucel in Infant Acute Lymphobl..:

Moskop, Amy ; Pommert, Lauren ; Baggott, Christina...
qt7bx8v22b.  , 2022
Link: https://escholarship.org..
 
1-15